Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  2002-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1139/Y02-079PMID 12117305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma membrane associated ATP as a regulator of the secretory activity of the pancreatic beta-cell.

  2009cited by this paper
• 2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors.

  1999cited by this paper
• Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells.

  1999cited by this paper
• 2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.

  1999cited by this paper
• Comparative effects of adenosine‐5′‐triphosphate and related analogues on insulin secretion from the rat pancreas

  1997cited by this paper
• ATP-induced intracellular Ca2+ signals in isolated human insulin-secreting cells

  1994cited by this paper
• In Vivo and in Vitro Effects of Adenosine‐5′‐0‐(2‐thiodiphosphate) on Pancreatic Hormones in Dogs

  1994cited by this paper
• Purinergic receptors on insulin‐secreting cells

  1994cited by this paper
• Nomenclature and classification of purinoceptors.

  1994cited by this paper
• Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2y‐purinoceptor agonist, adenosine‐5′‐O‐(2‐thiodiphosphate)

  1993cited by this paper
• Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines.

  1992cited by this paper
• P2y purinoceptor responses of β cells and vascular bed are preserved in diabetic rat pancreas

  1992cited by this paper
• Difference in the potentiating effect of adenosine triphosphate and α,β‐methylene ATP on the biphasic insulin response to glucose

  1989cited by this paper
• Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic β‐cells

  1989cited by this paper
• Difference in the potentiating effect of adenosine triphosphate and alpha, beta-methylene ATP on the biphasic insulin response to glucose.

  1989cited by this paper
• Comparison of the inhibition of insulin release by activation of adenosine and alpha 2-adrenergic receptors in rat beta-cells.

  1989cited by this paper
• ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor.

  1986cited by this paper
• Evidence for presence of insulin receptors in rat islets of Langerhans.

  1980cited by this paper
• Adenylate Cyclase in Islets of Langerhans

  1973cited by this paper
• Adenylate cyclase in islets of Langerhans. Isolation of islets and regulation of adenylate cyclase activity by various hormones and agents.

  1973cited by this paper
• Transport of Potassium Ions in the Rat's Intestine

  1963cited by this paper
• Stimulation of Secretion of Insulin by Adenosine-triphosphate

  1963cited by this paper

• A crucial role of adenosine deaminase in regulating gluconeogenesis in mice

  2024cites this paper
• The Purinergic Landscape of Type 2 Diabetes Mellitus

  2022cites this paper
• Diabetes and hypertension: Pivotal involvement of purinergic signaling

  2021cites this paper
• The role of Npas4 and Rgs2 in the regulation of pancreatic β-cell function

  2019cites this paper
• Opposing effects of intracellular versus extracellular adenine nucleotides on autophagy: implications for β-cell function

  2018influential citation
• Role of purinergic signalling and proinflammatory cytokines in diabetes

  2017cites this paper
• Important roles of P2Y receptors in the inflammation and cancer of digestive system

  2016cites this paper
• Regulatory role of adenosine in insulin secretion from pancreatic β-cells—Action via adenosine A1 receptor and beyond

  2015cites this paper
• Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations

  2015cites this paper
• P2X receptors and diabetes.

  2015cites this paper
• KCl -Permeabilized Pancreatic Islets: An Experimental Model to Explore the Messenger Role of ATP in the Mechanism of Insulin Secretion

  2015cites this paper
• Purinergic signalling in endocrine organs

  2014cites this paper
• Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes.

  2014cites this paper
• Characterisation of the P2Y14 receptor in the pancreas: control of vascular tone and insulin secretion

  2014cites this paper
• At the center of the circle: purinergic signaling in the autocrine loops of pancreatic islets

  2013cites this paper
• Purinergic signalling and cancer

  2013cites this paper
• Ectonucleotidase NTPDase3 is abundant in pancreatic β-cells and regulates glucose-induced insulin secretion.

  2013cites this paper
• P2Y1 receptor‐dependent diacylglycerol signaling microdomains in β cells promote insulin secretion

  2013cites this paper
• Ectonucleotidase NTPDase 3 is abundant in pancreatic β cells and regulates 1 glucose induced insulin secretion

  2013cites this paper
• Modulation of P2 receptors on pancreatic β-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment.

  2013cites this paper
• Autocrine regulation of insulin secretion

  2012cites this paper
• Improved blood glucose disposal and altered insulin secretion patterns in adenosine A(1) receptor knockout mice.

  2012cites this paper
• 2012 Landes Bioscience. Do not distribute. Glucose decreases extracellular adenosine levels in isolated mouse and rat pancreatic islets

  2012cites this paper
• Glucose decreases extracellular adenosine levels in isolated mouse and rat pancreatic islets

  2012cites this paper
• The CD39-Adenosinergic Axis in the Pathogenesis of Immune and Nonimmune Diabetes

  2012cites this paper
• Purinergic signalling in the pancreas in health and disease.

  2012cites this paper
• Role of TRPV 1 channel and P 2 Y 1 receptor in Ca 2 + signalling in β-cells : A study by single cell microfluorometry Kalaiselvan

  2011cites this paper
• Roles of the Transient Receptor Potential Channels and the Intracellular Ca 2 + Channels in Ca 2 + Signaling in the-cells

  2011cites this paper
• Involvement of P2X Receptors in the Regulation of Insulin Secretion, Proliferation and Survival in Mouse Pancreatic β-Cells

  2011cites this paper
• Effects of adenosine A(1) receptor antagonism on insulin secretion from rat pancreatic islets.

  2011cites this paper
• Activation of distinct P2Y receptor subtypes stimulates insulin secretion in MIN6 mouse pancreatic beta cells.

  2010cites this paper
• The insulin secretory granule as a signaling hub.

  2010cites this paper
• DP ribose is an endogenous ligand for the purinergic P 2 Y 1 receptor manda

  2010cites this paper
• Étude de la localisation et de la fonction de la nucléoside triphosphate diphosphohydrolase-3 dans le système digestif

  2010influential citation
• Identification of the ectonucleotidases expressed in mouse, rat, and human Langerhans islets: potential role of NTPDase3 in insulin secretion.

  2010cites this paper
• P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.

  2009cites this paper
• Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase‐3

  2009cites this paper
• TRPM2 Functions as a Lysosomal Ca2+-Release Channel in β Cells

  2009cites this paper
• Adenosine A1 and A2a receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep.

  2009cites this paper
• Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.

  2009cites this paper
• Title Purinergic P 2 X 7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival Permalink

  2009cites this paper
• Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival

  2009cites this paper
• Evidence for the possible involvement of the P2Y6 receptor in Ca2+ mobilization and insulin secretion in mouse pancreatic islets

  2008cites this paper
• Purinergic receptors in the endocrine and exocrine pancreas

  2008cites this paper
• Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors.

  2008cites this paper
• Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity.

  2008cites this paper
• Dual Effect of ATP on Glucose-Induced Insulin Secretion in HIT-T15 Cells

  2008influential citation
• Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion

  2008cites this paper
• Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.

  2007cites this paper
• Compartmentalized autocrine signaling to cystic fibrosis

  2007cites this paper
• Imidazole‐induced elevations of intracellular calcium in HL‐60 cells: effect of inhibition of phospholipase C by the steroidal maleimide U73122

  2006cites this paper
• Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides

  2006cites this paper
• Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility.

  2005cites this paper
• Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors.

  2005cites this paper
• Pulses of external ATP aid to the synchronization of pancreatic beta-cells by generating premature Ca(2+) oscillations.

  2004cites this paper
• Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders.

  2004cites this paper